Trade Ideas

Actionable trade ideas with defined risk and time horizons.

Curated trade ideas across equities, options, and other instruments, featuring clear directional bias, time horizon, and risk considerations. Trade ideas are designed to align market context, technical structure, and risk management principles.

Articles

6,042 total articles

SoftBank: A Deep-Value AI HoldCo with Multiple Paths to Unlocking $25+

SoftBank: A Deep-Value AI HoldCo with Multiple Paths to Unlocking $25+

SoftBank Group (SFTBY) is trading at $18.76 with a market cap near $223.6B, a trailing P/E around 8.7 and a P/B of 1.76. The company is a diversified holding company whose value is increasingly tied to AI infrastructure (Arm, Vision Fund portfolio, Exol) and Japan telecom assets. With several near-term catalysts — PayPay IPO momentum, Exol rollouts…

Paccar Setup: Earnings Beat Could Trigger Re-rating — Tactical Long

Paccar Setup: Earnings Beat Could Trigger Re-rating — Tactical Long

Paccar's recent fundamentals and market positioning suggest a higher-than-consensus earnings outcome is likely. Free cash flow, parts resilience, and improving momentum argue for a tactical long over the next 45 trading days to capture a re-rating if results surprise. Entry at the current price, tight stop and two stepped targets balance risk/rewar…

Prenetics: IM8’s $100M AAR Subscription Engine Is the Re-rating Catalyst Investors Are Underestimating

Prenetics: IM8’s $100M AAR Subscription Engine Is the Re-rating Catalyst Investors Are Underestimating

Prenetics has built an early-stage subscription engine through IM8 that already surpassed $100M in annualized recurring revenue within its first year. The company sits on $171.1M of adjusted liquidity, no debt, and a lean float. If management converts a larger share of buyers to quarterly subscriptions and scales international distribution, revenue…

Century Therapeutics: Low-Price Optionality on iPSC Cell Therapies

Century Therapeutics: Low-Price Optionality on iPSC Cell Therapies

Century Therapeutics (IPSC) offers asymmetric upside for traders who want exposure to off-the-shelf iPSC-derived cell therapy programs. The stock trades around $2.25 with a market cap near $400M, negative free cash flow, but a string of clinical and preclinical catalysts over the next 6-12 months that could re-rate sentiment. This is a mid-term swi…

The New Void Within Apple: A Tactical Short for the Mid-Term

The New Void Within Apple: A Tactical Short for the Mid-Term

Apple's next chapter is starting under new leadership at a moment when valuation premium, reliance on buybacks, and an uncertain product roadmap leave the stock vulnerable. We lay out a mid-term (45 trading days) short with entry at $273.44, a stop at $289.00 and a target of $245.00—an actionable trade that balances technical momentum against struc…

Hexcel: Operating Leverage Kicks In — Buy for a 180-Day Run

Hexcel: Operating Leverage Kicks In — Buy for a 180-Day Run

Hexcel (HXL) looks like a classic cyclical recovery turning structural growth story. With aerospace production heading higher, rising composite content in new airframes, and improving operating leverage visible in cash flow and profitability metrics, the setup supports a long trade. Valuation is rich on headline multiples, but improving FCF and a c…

Fossil Group: India IPO Could Be the Catalyst for a Re-rate to $20

Fossil Group: India IPO Could Be the Catalyst for a Re-rate to $20

Fossil Group is a small-cap watch and accessories company trading at about $5. The company’s ongoing debt restructuring and growing interest in an India IPO create a binary catalyst: a successful India listing or clear restructuring path could drive a re-rating to consumer and emerging-market multiples. This trade idea targets $20 with a $3.75 stop…

Oklo: A High-Conviction Long on Nuclear Powering AI Data Centers

Oklo: A High-Conviction Long on Nuclear Powering AI Data Centers

Oklo is a pre-revenue small modular reactor developer uniquely positioned to supply reliable, carbon-free power to hyperscale AI data centers. Recent partnerships with Nvidia, government space-nuclear initiatives, and reported commercial projects have re-priced the stock. The trade: take a long position at market, sized to risk tolerance, with a st…

Marvell: Positioning for the AI Data-Center Wave

Marvell: Positioning for the AI Data-Center Wave

Marvell is sitting at the intersection of networking, storage and photonics just as hyperscalers pour capex into AI infrastructure. The company’s technology stack, recent photonics push, attractive free cash flow and strong hyperscaler relationships make a compelling trade: a long entry at $170 targeting $210 over a 180-trading-day horizon with a $…

Alkane Resources (ALKEF) — Buy the Dip After the 2026 Rally; Tactical Swing Play with Defined Risk

Alkane Resources (ALKEF) — Buy the Dip After the 2026 Rally; Tactical Swing Play with Defined Risk

ALKEF has already run hard in 2026, but price structure, neutral RSI, and sizable historical short interest paint a tactical buying opportunity. Enter at $1.19 with a stop at $0.95 and a target at $1.70 for a mid-term swing (45 trading days). Keep position size disciplined—this is a trade that leans on technicals and the potential for episodic shor…

Ford's EV Shake-Up Is a Speed Bump, Not a Roadblock - A Mid-Term Trade Idea

Ford's EV Shake-Up Is a Speed Bump, Not a Roadblock - A Mid-Term Trade Idea

Ford announced a reorganization after the departure of its high-profile EV chief. The market sold off modestly, but fundamentals - strong free cash flow, cheap valuation metrics, and execution levers in product and fleet channels - argue for a measured long trade. This idea outlines an entry, stop, target and the rationale behind a mid-term (45 tra…

Why Sirius XM's Strange Rally Is Part Squeeze, Part Value Play

Why Sirius XM's Strange Rally Is Part Squeeze, Part Value Play

Sirius XM has ripped from its 52-week low to trade near $28 on a mix of short-covering, activist/stakeholder support and still-solid cash generation. The setup is buyable for a swing trade if you respect technical overbought conditions and use a tight stop. Valuation (P/E ~12, P/B ~0.79, FCF yield north of 12%) and a healthy $1.245B free cash flow …

Bank OZK — Cheap Now, Expensive to Ignore

Bank OZK — Cheap Now, Expensive to Ignore

Bank OZK (OZK) trades at a sub-1x P/B and under 8x P/E despite a 63-quarter dividend increase streak, healthy liquidity, and bullish technicals. We initiate a position for a 180-trading-day horizon with an entry at $48.50, a stop at $44.00 and a target of $60.00. Risk is real — concentration and credit cycles matter — but the market appears to unde…

Kraft Heinz: Cheap Enough That a Modest Recovery Looks Big

Kraft Heinz: Cheap Enough That a Modest Recovery Looks Big

Kraft Heinz is priced like a company with persistent deterioration, but its balance sheet, free cash flow and an outsized dividend create a high-reward asymmetric trade if management can merely stabilize revenue and margins. Enter a tactical long on weakness with tight risk control and a 45-trading-day horizon.

Carriage Services: Buy the Predictable Cash Flow, Trim the Volatility

Carriage Services: Buy the Predictable Cash Flow, Trim the Volatility

Carriage Services (CSV) is a cash-generative consolidator in funeral and cemetery services. At about $50, the stock trades at roughly 15x earnings with $40m in free cash flow and a high return on equity. I recommend a mid-term long: enter at $50.00, target $60.00, stop $45.00. Catalysts include an upcoming dividend, active M&A, and operational lead…